HOME >> BIOLOGY >> NEWS
NIAID unveils bioterrorism research agenda

mechanisms of potential bioterror pathogens. Such information, which includes sequencing of each microbe's genome, will provide the information needed to develop new drugs and vaccines to combat possible bioterrorism-caused diseases.
  • Human immune response. Increased research on the basic components of the human immune system will enable scientists to develop safe and potent vaccines, highly accurate diagnostic tests, and broadly acting drugs that boost overall immunity to a range of pathogens.
  • Vaccines. Vaccines are one of the most effective ways to protect people from infectious diseases, and accelerated research on new vaccines is underway. New Ebola and anthrax vaccines will soon enter human testing, and research on improved smallpox and tularemia vaccines is ongoing. Additional research has been conducted on ways to stretch current smallpox vaccine stockpiles for the short term.
  • Treatments. The increase in antibiotic resistance among bacteria and the relative scarcity of effective antiviral drugs make treatment research imperative. Scientists will use information gained from basic studies of a microbe's biology and genetic makeup to develop compounds that specifically destroy that organism or its toxins. Research on new treatments for pathogens such as smallpox and anthrax are currently underway.
  • Diagnostics. An effective response against a bioterrorist attack requires rapid, accurate identification of both natural and bioengineered microbes. Information on a pathogen's sensitivity to available drugs will also help doctors quickly treat anyone who has become infected. New early warning and diagnostic tests are a key part of NIAID's bioterrorism research agenda.
  • Research resources. Research on the five general areas above requires a broad range of resources including genomic information, novel reagents, animal models of disease, and high-containment laboratories and clinical facilities. NIAID will pr
    '"/>


  • Contact: Sam Perdue
    sp189u@nih.gov
    301-402-1663
    NIH/National Institute of Allergy and Infectious Diseases
    14-Mar-2002


    Page: 1 2 3 4

    Related biology news :

    1. TIGR and NIAID sign $65 million microbial sequencing contract
    2. NIAID takes next genome step
    3. NIAID awards grant to rapidly sequence the malaria mosquito genome
    4. NIAID launches major step in trial of experimental shingles vaccine
    5. NIAID-Supported Scientists Discover Origin Of HIV-1
    6. NIAID Scientists Discover HIV Disease-Slowing Mutation
    7. NIAID Doctor Successfully Treats Longest Case Of Malaria Infection On Record
    8. Pacific Northwest team unveils largest virus proteome to date
    9. Pacific Northwest National Lab unveils most complete human blood-plasma proteome map to date
    10. Department of Energys Office of Science unveils 20-year vision for the future of basic research
    11. Ancient DNA analysis unveils mystery of historys most horribly deformed man -- The Elephant Man

    Post Your Comments:
    *Name:
    *Comment:
    *Email:


    (Date:12/5/2018)... ... December 04, 2018 , ... ... the much-anticipated launch of their 100-liter (26 gallon) SAFEthread Drum. The 100-liter ... in 2017, which brought a much-needed modern redesign to the plastic drums being ...
    (Date:11/29/2018)... ... November 29, 2018 , ... ACEA ... the new NSF Engineering Research Center for Cell Manufacturing Technologies (CMaT). ... develop transformative tools and technologies for the consistent, scalable and low-cost production of ...
    (Date:11/27/2018)... ... November 26, 2018 , ... uBiome, ... Founder of the website IBDwatch and Gastroenterology Fellow at the University of Louisville, ... from around the world, Dr. Wuerth will bring to uBiome knowledge and research ...
    Breaking Biology News(10 mins):
    (Date:11/20/2018)... ... 20, 2018 , ... Each year Forbes receives thousands of nominations for candidates ... performance by individuals under 30 years of age. The Forbes 30 Under 30 list ... Entertainment to Venture Capital and Science. , In 2017, Visikol CEO Dr. Michael ...
    (Date:11/15/2018)... ... November 14, 2018 , ... ... first self-learning snore-reduction mask to the public. It is estimated that 90 ... sleep for themselves and their partner. The resulting daytime fatigue causes extreme difficulty ...
    (Date:11/13/2018)... (PRWEB) , ... November 12, 2018 , ... ... to reduce stethoscope contamination that two large U.S. studies, published last week, confirm ... the American Journal of Infection Control (AJIC) conclude that stethoscopes are often improperly ...
    (Date:11/13/2018)... BOSTON (PRWEB) , ... November 13, 2018 , ... ... an analysis of the spine technology market last week that asserts it is ... global patient population. , Humad’s analysis describes market consolidation, pricing pressure ...
    Breaking Biology Technology:
    Cached News: